{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Result display time: 3 min
Sample volume: 0.035 ml
... the FREND™ System. It is designed for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab specimens directly from individuals suspected with COVID-19 by their healthcare ...
NanoEntek
Result display time: 3 min
Sample volume: 0.035 ml
Specificity: 95.6, 100, 97.5 %
... and simultaneous detection of the nucleocapsid protein of SARS-CoV-2 and Influenza A&B virus. It measures directly from nasopharyngeal swab specimens. KEY FEATURES & BENEFITS - 2 steps | Easy to use - Microfluidic ...
NanoEntek
Result display time: 3 min
Sample volume: 0.035 ml
Specificity: 100 %
... POCT) which can be used to measure Influenza A virus and Influenza B virus in human nasopharyngeal swab specimen. KEY FEATURES & BENEFITS - Easy to use - Accurate test result - Microfluidic Qualitative ...
NanoEntek
Please specify:
Help us improve:
remaining